Biotech News
@FierceBiotech: Vitamin D boosts TB shot as cancer therapy. More | Follow @FierceBiotech
@RyanMFierce: Pfizer brings Lipitor brand to mobile app stores. Report | Follow @RyanMFierce
@JohnCFierce: So Globe's verastem coverage says best-case scenario is start trials in a year, products available in four. A three-year cancer stem cell program? Ha. | Follow @JohnCFierce
> It's the end of an era at Amgen ($AMGN) as Kevin Sharer steps down as CEO and hands the reins of the big biotech to Bob Bradway. Story
> Denmark's Veloxis is circling the wagons around its lead therapy to prevent organ rejection. The biotech says it plans to cut anywhere from 25 to 30 staffers from its 60-person employee roster. Release
> U.K. science minister David Willets is expected to announce £250 million in fresh support for the country's life sciences industry today. Story
> Bloomberg makes the case that GlaxoSmithKline's ($GSK) propensity for buying biotechs it collaborates with points to possible M&A moves in the future. Report
> Blueprint Medicines says that Fidelity Biosciences has joined the lineup of venture groups involved in its $40 M A round announced earlier. Stephen Knight, the managing partner at Fidelity, has joined the Blueprint board. Release
Pharma News
@FiercePharma: Another German drugmaker in takeover talks: Riemser may pick shortlist by next week--Bloomberg. Story | Follow @FiercePharma
> New Teva chief slashes sales forecast by $1B. News
> EU antitrust officials probe parallel trade. Article
> Securities watchdogs reportedly probe Shanghai Pharma deals. Item
> FDA panel draws blood in Xarelto's bid for new use. Report
Medical Device News
@FierceMedDev: HeartWare gained expanded European approval for its HVAD implant. Trials continue in the U.S., however. Story | Follow @FierceMedDev
@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
> Orrin Hatch pulls device tax repeal amendment from user fee bill. Report
> Once spectrum is approved, wireless patient monitors still face obstacles. Article
> Alere recalls thousands of cardiac diagnostic tests. More
> House Republicans push for tax-repeal vote. Item
Pharma Manufacturing News
@EricPFierce: FDA to Crescendo: We told you so. Marshals seize steroid gel from California firm that was selling unapproved drug. Report | Follow @EricPFierce
> FDA may impose more QA checks on heparin makers. Story
> Recipharm snags $114 million loan, says its shopping. Article
> Heart attack test alert from Alere. More
> FDA takes aim at Spanish drugmaker. Item
CRO News
@NesaNFierce: What should a CDMO do with 90 million Euros? Buy more CDMOs, as Recipharm announced it will do. Article | Follow @NesaNFierce
> SGS picks up testing company Vitrology for an undisclosed fee. News
> Pfizer's David Simmons joins PPD as new CEO and chairman. Story
> PRA expands European ops with new Dutch and British offices. More
> Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement. Item
Vaccines News
> Wishing you a happy HIV Vaccine Awareness Day. Report
> Vitamin D boosts TB shot as cancer therapy. Article
> DNA vaccine swats TB and HIV. News
> HIV vaccine carries its own adjuvant into clinical trials. Story
And Finally... A new study indicates that certain "obesity genes" may influence the foods that are chosen by people who are overweight. More